MDxHealth (MDXH) Net Cash Flow (2021 - 2026)

MDxHealth has disclosed Net Cash Flow across 5 years of filings, most recently posting $14.1 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $14.1 million, down 25.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.7 million (down 138.5% YoY), and the FY2025 annual result was -$17.8 million, down 197.55% from the prior year.
• Net Cash Flow came in at $14.1 million for Q1 2026 at MDxHealth, up from -$14.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $27.9 million in Q3 2024 to a low of -$14.8 million in Q3 2025.
• The 4-year median for Net Cash Flow is -$8.2 million (2022), against an average of $674875.0.
• Across the five-year window, Net Cash Flow plunged 153.0% in 2025 and declined 25.14% in 2026, its largest moves.
• MDxHealth's Net Cash Flow stood at -$7.7 million in 2022, then declined by 12.81% to -$8.7 million in 2024, then sank by 71.0% to -$14.8 million in 2025, then jumped by 195.43% to $14.1 million in 2026.
• The last three Net Cash Flow figures came in at $14.1 million (Q1 2026), -$14.8 million (Q3 2025), and -$14.0 million (Q2 2025), per Business Quant data.